OTC · CIK 0001443863
BICX BioCorRx Inc.
Insider trading from SEC Form 4. Last filing Jan 31, 2025. Close $0.25 on Oct 12, 2026, +64% from the 52-week low and -49% from the high.
In brief
BioCorRx Inc. (BICX) has 20 SEC Form 4 filings on file from 6 insiders, the latest filed on Jan 31, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
3 open-market trades have been scored at BICX. The newest: Louis C. Lucido (Interim President) bought $2,188 of stock on Jan 12, 2024, filed Jan 17, 2024, scored 33 (weak). The largest of the 3 shown: Louis C. Lucido (President) bought $4,170 on Dec 12, 2022, scored 36 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BioCorRx Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Louis C. Lucido Interim President buy | $2,188 3,126 shares | +1% | +4% from low-68% from high | |
| 36Weak | Louis C. Lucido President buy | $4,170 5,000 shares | +6% | 0% from low-84% from high | |
| 33Weak | Louis C. Lucido President buy | $3,126 1,590 shares | +2% | 0% from low-60% from high |
Transactions
Every row filed, 46 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 24, 2024 | Louis C. Lucido President | JOther Common Stock, par value $0.001 | +460,477 | $0.00 | $0 | 1,083,293 | Jan 31, 2025 |
| Apr 24, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +224,196 | $0.00 | $0 | 314,795 | Jan 31, 2025 |
| Jul 31, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +32,092 | $0.00 | $0 | 1,115,385 | Jan 31, 2025 |
| Jul 2, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +500,000 | $0.00 | $0 | 814,795 | Jan 31, 2025 |
| Sep 30, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +15,625 | $0.00 | $0 | 830,420 | Jan 31, 2025 |
| Aug 30, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +55,559 | $0.00 | $0 | 1,170,944 | Jan 31, 2025 |
| Sep 30, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +52,085 | $0.00 | $0 | 1,223,029 | Jan 31, 2025 |
| Dec 31, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +13,158 | $0.00 | $0 | 843,578 | Jan 31, 2025 |
| Sep 30, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +15,625 | $0.00 | $0 | 1,238,654 | Jan 31, 2025 |
| Oct 14, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +1,105,218 | $0.00 | $0 | 2,343,872 | Jan 31, 2025 |
| Oct 31, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +55,556 | $0.00 | $0 | 2,399,428 | Jan 31, 2025 |
| Nov 29, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +55,494 | $0.00 | $0 | 2,454,922 | Jan 31, 2025 |
| Dec 31, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +43,860 | $0.00 | $0 | 2,498,782 | Jan 31, 2025 |
| Dec 31, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +13,158 | $0.00 | $0 | 2,511,940 | Jan 31, 2025 |
| Jun 28, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +10,204 | $0.00 | $0 | 588,800 | Jul 10, 2024 |
| Jun 28, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +34,016 | $0.00 | $0 | 622,816 | Jul 10, 2024 |
| Jun 28, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +10,204 | $0.00 | $0 | 90,599 | Jul 8, 2024 |
| Mar 28, 2024 | Luisa Ingargiola director | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 53,987 | Jul 8, 2024 |
| Jun 28, 2024 | Luisa Ingargiola director | AGrant or award Common Stock, par value $0.001 | +10,204 | $0.00 | $0 | 64,191 | Jul 8, 2024 |
| May 31, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +22,831 | $0.00 | $0 | 578,596 | Jun 3, 2024 |
| Apr 30, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +21,552 | $0.00 | $0 | 555,765 | May 1, 2024 |
| Jan 2, 2024 | Joseph J Galligan director, owner | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 232,292 | Apr 5, 2024 |
| Mar 28, 2024 | Joseph J Galligan director, owner | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 237,858 | Apr 5, 2024 |
| Mar 28, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 80,395 | Apr 3, 2024 |
| Mar 28, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 515,660 | Apr 3, 2024 |
| Mar 28, 2024 | Brady James Granier President | AGrant or award Stock Optionderivative | +16,698 | $0.00 | $0 | 16,698 | Apr 3, 2024 |
| Jan 2, 2024 | Harsha Murthy director | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 14,153 | Apr 3, 2024 |
| Mar 28, 2024 | Harsha Murthy director | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 19,719 | Apr 3, 2024 |
| Mar 28, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +18,553 | $0.00 | $0 | 534,213 | Apr 3, 2024 |
| Jan 31, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +18,269 | $0.00 | $0 | 493,202 | Mar 7, 2024 |
| Feb 29, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +16,892 | $0.00 | $0 | 510,094 | Mar 7, 2024 |
| Jan 12, 2024 | Louis C. Lucido Interim President | POpen-market purchase Common Stock, par value $0.001 | +3,000 | $0.70 | $2,100 | 474,807 | Jan 17, 2024 |
| Jan 16, 2024 | Louis C. Lucido Interim President | POpen-market purchase Common Stock, par value $0.001 | +126 | $0.70 | $88 | 474,933 | Jan 17, 2024 |
| Jan 2, 2024 | Luisa Ingargiola director | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 48,421 | Jan 4, 2024 |
| Jan 2, 2024 | Louis C. Lucido President | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 471,807 | Jan 4, 2024 |
| Jan 2, 2024 | Brady James Granier President | AGrant or award Stock Optionderivative | +18,519 | $0.00 | $0 | 18,519 | Jan 4, 2024 |
| Jan 2, 2024 | Lourdes Felix CEO and CFO | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 74,829 | Jan 4, 2024 |
| Dec 12, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $0.79 | $790 | 85,425 | Dec 15, 2022 |
| Dec 12, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $0.98 | $980 | 86,425 | Dec 15, 2022 |
| Dec 12, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $0.80 | $800 | 87,425 | Dec 15, 2022 |
| Dec 12, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +2,000 | $0.80 | $1,600 | 89,425 | Dec 15, 2022 |
| Sep 6, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +10 | $2.10 | $21 | 82,845 | Oct 11, 2022 |
| Oct 5, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $2.02 | $2,020 | 83,845 | Oct 11, 2022 |
| Oct 6, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +360 | $1.90 | $684 | 84,205 | Oct 11, 2022 |
| Oct 6, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +120 | $1.90 | $228 | 84,325 | Oct 11, 2022 |
| Oct 6, 2022 | Louis C. Lucido President | POpen-market purchase Common Stock, par value $0.001 | +100 | $1.73 | $173 | 84,425 | Oct 11, 2022 |
Insiders
Everyone who has filed a Form 4 here.
- Lourdes FelixCEO and CFO
- Joseph J Galligandirector, owner
- Brady James GranierPresident
- Luisa Ingargioladirector, officer
- Louis C. LucidoPresident
- Harsha Murthydirector
Questions about BICX
Answered from the filings on this page, as of the latest one.
Are insiders buying BICX?
No. In the last 90 days no insider at BioCorRx Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BICX on the open market?
Louis C. Lucido (Interim President) bought $2,188 of BICX on Jan 12, 2024 and filed the Form 4 on Jan 17, 2024. InsiderTell scored 33 (weak).
How many insiders file Form 4 at BioCorRx Inc.?
6 people have filed a Form 4 at BioCorRx Inc., among them Lourdes Felix (CEO and CFO), Joseph J Galligan (director and 10% owner), Brady James Granier (President). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.